Personalized chemo dosing aims to boost surgery success in stomach cancer
NCT ID NCT02366819
First seen May 05, 2026 · Last updated May 07, 2026 · Updated 1 time
Summary
This study tests whether adjusting chemotherapy doses based on a patient's genetic makeup can improve outcomes for people with advanced stomach or esophageal cancer that has spread to nearby tissues or lymph nodes. About 36 participants will receive a combination of four chemotherapy drugs before and after surgery. The main goal is to see if this approach increases the chance of completely removing the tumor during surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kellogg Cancer Center - Evanston Hospital
Evanston, Illinois, 60201, United States
-
NorthShore University HealthSystem
Evanston, Illinois, 60201, United States
-
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.